
==== Front
PeerJ
PeerJ
peerj
PeerJ
2167-8359
PeerJ Inc. San Diego, USA

18085
10.7717/peerj.18085
Cardiology
Hematology
Internal Medicine
Pediatrics
Value of preoperative prognostic nutritional index combined with NT-proBNP in predicting acute kidney injury of congenital heart disease children
Qiao Yan
Lv Zhenqian
Liu Xiaojun
Zhou Baoguo
Wang Haiping
Wang Gang
Xie Aiping
Cheng Chenchen xingchen-102@163.com

Cardiovascular Surgery, Qingdao Cardiovascular Hospital, Qingdao, Shandong, China
Shi Huashan
18 9 2024
2024
12 e1808518 6 2024
21 8 2024
©2024 Qiao et al.
2024
Qiao et al.
https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits using, remixing, and building upon the work non-commercially, as long as it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.

Objective

The study investigates value of preoperative prognostic nutritional index (PNI) combined with N-terminal pro-brain natriuretic peptide (NT-proBNP) in predicting postoperative acute kidney injury (AKI) in congenital heart disease (CHD) children.

Methods

The clinical data of 108 children with congenital heart disease were retrospectively collected. According to whether AKI occurred 48 h after operation, they were divided into AKI group (n = 32) and non-AKI group (n = 76). The clinical data, preoperative PNI and NT-proBNP levels were compared between the two groups. Multivariate logistic regression analysis was used to analyze the influencing factors of AKI, and the receiver operating characteristic (ROC) curve was drawn to evaluate the predictive value of preoperative PNI, NT-proBNP and their combination.

Results

Multivariate logistic regression analysis showed that Scr, PNI and NT-proBNP were independent risk factors for postoperative AKI in children with congenital heart disease (P < 0.001). The results of ROC curve analysis showed that the area under the curve (AUC) of preoperative PNI, NT-proBNP and their combination in predicting postoperative AKI in children with congenital heart disease were 0.839, 0.738 and 0.907, respectively, and the AUC of their combination was the highest.

Conclusion

The combined use of preoperative PNI as well as NT-proBNP holds significant value in predicting postoperative AKI in CHD children. Monitoring preoperative PNI and NT-proBNP levels may aid in clinically identifying the risk of postoperative AKI in CHD children, thereby improving their prognosis.

Congenital heart disease
Acute kidney injury
Prognostic nutrition index
Children
N-terminal B-type brain natriuretic peptide precursor
The authors received no funding for this work.
==== Body
pmcIntroduction

Congenital heart disease refers to structural abnormalities in the heart formed during embryonic development, including atrial septal defect, ventricular septal defect, patent ductus arteriosus as well as tetralogy of Fallot. Congenital heart disease is a common type of birth defect in China, with epidemiological statistics (The Writing Committee of the Report on Cardiovascular Health and Diseases in China & Hu, 2023) showing an incidence of approximately 8.98%, and it is on the rise, significantly impacting the safety of affected children. Currently, surgical intervention is the primary method for clinical treatment of congenital heart disease. However, postoperative acute kidney injury (AKI) is common in CHD children, with an incidence ranging from 10% to 45% (Khuong et al., 2021). It is closely associated with the occurrence of short-term and long-term adverse events after surgery (Van den Eynde et al., 2021). Therefore, early detection of AKI in CHD children after cardiac surgery while timely and effective clinical intervention are crucial for reducing mortality rates in affected children.

In the past, AKI diagnosis relied on degree of serum creatinine (Scr) elevation clinically. However, due to non-renal factors, Scr typically peaks 1 to 3 days after cardiac surgery, leading to limitations in sensitivity and other inadequacies (Beken et al., 2021). Research indicates (Parker et al., 2019) that N-terminal pro-B-type natriuretic peptide (NT-proBNP) has certain predictive value in adults AKI after cardiac surgery, but its standalone predictive value is not high. Excessive activation of systemic inflammatory response is considered a significant cause of AKI after cardiac surgery. Previous studies (Xie et al., 2022) have shown that albumin has multiple renal protective effects, and preoperative hypoalbuminemia may increase postoperative AKI risk. The prognostic nutritional index (PNI), calculated based on patient’s plasma albumin and absolute lymphocyte count, can simultaneously reflect the patient’s plasma albumin level and overall inflammatory status, demonstrating good predictive efficacy for postoperative renal complications in adult cardiac surgery (Liu et al., 2023).

Currently, there is no research analyzing predictive value of preoperative PNI combined with NT-proBNP in postoperative AKI in CHD children. The current study primarily aims to analyze predictive value of preoperative PNI combined with NT-proBNP in postoperative AKI in CHD children, providing a reference for clinical prevention and treatment of AKI.

Materials and Methods

Subject selection

The retrospective collection of data was performed on 108 CHD children who underwent cardiac surgery between June 2020 and August 2023. Inclusion criteria demonstrated as: (1) have been diagnosed as congenital heart disease and met the indications for congenital heart disease extracorporeal circulation surgery; (2) age < 14 years; (3) complete laboratory and clinical data. Exclusion criteria were as follows: (1) Preoperative chronic kidney disease or renal dysfunction.; (2) history of renal surgery or exposure to nephrotoxic drugs; (3) emergency surgery; (4) comorbid malignancy or hematological disorders; (5) incomplete case data.

Grouping method: 108 children with congenital heart disease were divided into AKI group (n = 32) and non-AKI group (n = 76) according to whether AKI occurred 48 h after operation. AKI diagnostic criteria: According to the clinical practice guidelines for acute kidney injury of Kidney Disease: Improving Global Outcomes (KDIGO) (Khwaja, 2012), AKI can be defined as one of the following conditions: (1) serum creatinine (SCr) increased by ≥ 0.3 mg/dl (26.5 µmol/L) within 48 h; (2) Known or assumed that renal dysfunction occurred within 7 days, SCr increased to ≥ 1.5 times the baseline value; (3) Urine volume < 0.5 ml/(kg h) for 6 h. This study was approved by the Ethics Committee of Qingdao Cardiovascular Hospital and abided by the ethical guidelines of the Declaration of Helsinki.

The Ethics Committee agrees to waive informed consent.

Methods

Collection of data

Clinical data of all eligible children were collected through electronic medical records, including: (1) surgical information, such as age, gender, body mass index (BMI), type of CHD, Risk Adjustment for Congenital Heart Surgery-1 (RACHS-1) score, preoperative left ventricular ejection fraction (LVEF), duration of surgery, aortic cross-clamp time, cardiopulmonary bypass (CPB) time, postoperative mechanical ventilation time, and intensive care unit (ICU) stay; (2) laboratory indicators: The last laboratory data of all children before surgery were collected, including Scr, 24-hour urine volume, serum albumin, total number of peripheral blood lymphocytes, and NT-proBNP. Detection method: The total number of peripheral blood lymphocytes was detected by Roche Cobas 8000 automatic biochemical analyzer (Roche, Germany). 5 ml venous blood was collected at the last time before operation, placed in a centrifuge tube without anticoagulant, placed in a 37 °C water bath for 30 min, centrifuged with a centrifugal radius of 13.5 cm, and centrifuged at 3500 r/min for 10 min. The serum was separated and stored at −80 °C. Scr level was detected by microparticle enzyme immunoassay, and the kit was purchased from Siemens (Munich, Germany). The serum albumin level of the children was detected by immunoturbidimetry. The kit was purchased from Merck Reagent Company (Germany), and the operation was carried out according to the kit instructions. The serum NT-proBNP level was detected by enzyme-linked immunosorbent assay. The kit was purchased from Merck Reagent Company (Darmstadt, Germany), and the operation was carried out according to the kit instructions.

PNI calculation method (Xu et al., 2022)

The preoperative serum albumin and peripheral blood lymphocyte count of the patients were collected. The calculation formula is as follows: PNI = serum albumin (g/L) + 5 × peripheral blood lymphocyte count (×109/L).

Statistical methods

SPSS software version 23.0 (IBM, New York, USA) was used to analyze the data. Normally distributed continuous variables were presented as mean ± standard deviation. Comparison between groups was conducted using independent samples t-test. The categorical data were presented as “n (%)”. Comparison between groups was conducted with the chi-square test. Multiple-factor logistic regression analysis has been used to identify the influencing factors of postoperative AKI in CHD children. Pearson correlation analysis has been employed to explore relationship between preoperative PNI, NT-proBNP, and Scr. The receiver operating characteristic (ROC) curve was plotted using GraphPad 8.0 software to evaluate predictive value of preoperative PNI, NT-proBNP, as wel as their combination for postoperative AKI in CHD children. P < 0.05 was considered statistically significant.

Results

Comparison of surgical data between groups

Compared with the non-AKI group, the CPB time (P < 0.001), aortic occlusion time (P < 0.001), postoperative mechanical ventilation time (P < 0.001) and ICU hospitalization time (P < 0.001) in the AKI group were significantly longer, and the difference was statistically significant. No significant differences were observed in other surgical data such as gender and age between groups (P > 0.05, Table 1).

10.7717/peerj.18085/table-1 Table 1 Comparison of surgical data between AKI and non-AKI groups.

	AKI (n = 32)	Non-AKI (n = 76)	χ2/t	P	
Age (years, x¯±s)	4.12 ±0.53	4.53 ±0.71	1.576	0.118	
Gender, n (%)					
Male	18 (56.25)	42 (55.26)	0.009	0.925	
Female	14 (43.75)	34 (44.74)			
BMI (kg/m2, x¯±s)	68.97 ±3.15	68.05 ±4.22			
Type, n (%)					
Atrial/Ventricular septal defect	11 (34.38)	26 (34.21)	0.541	0.910	
Patent ductus arteriosus	13 (40.63)	33 (43.42)			
Tetralogy Fallot	7 (21.88)	13 (17.11)			
Others	1 (3.13)	4 (5.26)			
RACHS-1 grade, n (%)					
1	2 (6.25)	8 (10.53)	1.241	0.743	
2	16 (50.00)	39 (51.32)			
3	8 (25.00)	20 (26.32)			
4	6 (18.75)	9 (28.13)			
LVEF (%, x¯±s)	68.60 ±6.31	66.97 ±6.89	1.150	0.253	
Surgical time (min, x¯±s)	151.48 ±11.68	149.26 ±11.75	0.898	0.371	
CPB time (min, x¯±s)	101.65 ±3.64	74.25 ±4.19	32.209	<0.001	
Aortic cross-clamp time (min, x¯±s)	68.13 ±4.31	50.69 ±5.67	15.590	<0.001	
Ventilation time (h, x¯±s)	11.56 ±1.82	4.91 ±1.33	21.178	<0.001	
ICU stay (d, x¯±s)	9.15 ±0.46	4.28 ±0.85	30.527	<0.001	
Notes.

AKI acute kidney injury

RACHS-1 Risk Adjustment for Congenital Heart Surgery-1

LVEF left ventricular ejection fraction

CPB cardiopulmonary bypass

ICU intensive care unit

Comparison of laboratory data between groups

Compared with the non-AKI group, the Scr (P < 0.001) and NT-proBNP (P < 0.001) in the AKI group were significantly higher, and the albumin (P = 0.004) and PNI (P < 0.001) were significantly lower. The difference was statistically significant. No statistically significant differences in 24-hour urine output and total lymphocyte count between groups (P > 0.05, Table 2).

10.7717/peerj.18085/table-2 Table 2 Comparison of laboratory data between AKI and non-AKI groups.

	AKI (n = 32)	Non-AKI (n = 76)	t	P	
Scr (µmol/L)	481.25 ±80.62	109.47 ±25.41	36.334	<0.001	
24-hour urine output (ml/kg)	34.12 ±13.15	37.88 ±17.89	1.072	0.286	
Albumin (g/L)	43.15 ±6.97	46.83 ±5.35	2.975	0.004	
Total lymphocyte count (×109/L)	1.85 ±0.68	1.90 ±0.71	0.338	0.736	
PNI	43.29 ±6.94	47.02 ±3.34	3.776	<0.001	
NT-proBNP (pg/ml)	1015.47 ±162.35	801.36 ±88.94	8.808	<0.001	
Notes.

AKI acute kidney injury

Scr serum creatinine

PNI prognostic nutritional index

NT-proBNP N-terminal pro-B-type natriuretic peptide

Correlation analysis of preoperative PNI, NT-proBNP, and Scr in CHD children and concurrent AKI

Correlation analysis results indicated a negative correlation between preoperative PNI and Scr in CHD children and concurrent AKI (r =  − 0.424, 95% CI [−0.655 to −0.121], P = 0.008), as shown in Fig. 1. Furthermore, a positive correlation was observed between preoperative NT-proBNP and Scr in CHD children and concurrent AKI (r = 0.344, 95% CI [0.0271–0.598], P = 0.035), as illustrated in Fig. 2.

10.7717/peerj.18085/fig-1 Figure 1 Correlation between preoperative PNI and Scr in CHD children and concurrent AKI.

10.7717/peerj.18085/fig-2 Figure 2 Correlation between preoperative NT-proBNP and Scr in CHD children and concurrent AKI.

Multifactorial logistic regression model analysis of postoperative AKI in CHD children

Using the variables that showed statistically significant differences in univariate analysis as independent variables and postoperative AKI in CHD children as the dependent variable (assigned as: non-AKI = 0, AKI = 1), multifactorial logistic regression model analysis revealed that Scr (OR = 1.979, 95% CI [1.309∼2.993], P < 0.001), PNI (OR = 2.017, 95% CI [2.859∼15.536], P < 0.001), as well as NT-proBNP (OR = 1.698, 95% CI [2.697∼5.003], P < 0.001) were independent risk factors influencing postoperative AKI in CHD children (P < 0.001, Table 3).

10.7717/peerj.18085/table-3 Table 3 Multifactorial logistic regression model analysis of postoperative AKI in CHD children.

Factors	β	SE	Ward χ2	P	OR	95%CI	
CPB time	0.189	0.102	3.432	0.082	1.208	0.989∼1.475	
Aortic cross-clamp time	0.100	0.057	3.068	0.097	1.105	0.988∼1.236	
Ventilation time	0.107	0.094	1.297	0.182	1.113	0.926∼1.338	
ICU stay	0.275	0.182	2.289	0.114	1.317	0.922∼1.882	
Scr	0.683	0.211	10.465	<0.001	1.979	1.309∼2.993	
PNI	0.702	0.178	15.536	<0.001	2.017	2.859∼15.536	
NT-proBNP	0.529	0.236	5.033	<0.001	1.698	2.697∼5.003	
Notes.

CPB cardiopulmonary bypass

ICU intensive care unit

Scr serum creatinine

PNI prognostic nutritional index

NT-proBNP N-terminal pro-B-type natriuretic peptide

ROC curve analysis of preoperative PNI, NT-proBNP, and combined prediction for postoperative AKI in CHD children

The ROC curve showed that preoperative PNI and NT-proBNP had an area under the curve (AUC) of 0.839 (95% CI [0.751–0.927]) and 0.738 (95% CI [0.632–0.845]) in predicting postoperative AKI in CHD children. Optimal cutoff values were determined to be 44.5 and 987.3 pg/ml, respectively. The sensitivity was found to be 88.37% and 69.77%, while the specificity was 72.09% and 55.81% for PNI and NT-proBNP, respectively. When combined, the preoperative PNI and NT-proBNP showed the highest AUC of 0.907 (95% CI [0.836–0.981]), as presented in Fig. 3 and Table 4.

10.7717/peerj.18085/fig-3 Figure 3 ROC curve for preoperative PNI, NT-proBNP, and combined prediction for postoperative AKI in CHD children.

10.7717/peerj.18085/table-4 Table 4 ROC curve analysis of preoperative PNI, NT-proBNP, and combined prediction for postoperative AKI in CHD children.

	AUC	Optimal cutoff values	Sensitivity	Specificity	95% CI	P	
PNI	0.839	44.5	88.37	72.09	0.751∼0.927	<0.001	
NT-proBNP	0.738	987.3 pg/ml	69.77	55.81	0.632∼0.845	<0.001	
Combined	0.907		93.02	81.40	0.836∼0.981	<0.001	
Notes.

PNI prognostic nutritional index

NT-proBNP N-terminal pro-B-type natriuretic peptide

Discussion

Surgical intervention is the primary clinical treatment for CHD children, effectively saving their lives. AKI is a common complication after cardiac surgery in CHD children (Gist, Kwiatkowski & Cooper, 2018). In the current study, a total of 108 CHD children were included, among which, 32 cases developed AKI after surgery, accounting for 29.63%, which is consistent with previous literature reports (Xu et al., 2018). Recent research has found that AKI not only increases the short-term mortality and incidence of chronic disease in children but also imposes a significant impact on the long-term survival rates (Fuhrman et al., 2019). A large-scale retrospective analysis study indicated that AKI is a prognostic factor for CHD children, significantly reducing their survival rates. Moreover, the impact on survival rates becomes more pronounced with AKI severity (Nishida et al., 2019). Therefore, predicting occurrence of AKI after surgery in CHD children is of great significance for improving their prognosis.

In this study, the regression analyses were conducted, showing that Scr was an independent risk factor for postoperative AKI in CHD children (P < 0.001). This finding suggests a close association between Scr levels and the occurrence of AKI in CHD children. Scr is a crucial indicator commonly used in clinical practice to assess kidney function. AKI in CHD children has decreased glomerular filtration rate, resulting in accumulation of Scr in the blood. Therefore, in cases of postoperative AKI in CHD children, Scr levels often rise, indicating an increase in serum Scr concentration, which is clinically used to diagnose AKI based on the degree of Scr elevation (Alzahrani et al., 2022). However, due to the kidney’s reserve capacity, significant elevation of serum creatinine only occurs when renal function is severely impaired. Scr levels typically peak around 1–3 days after cardiac surgery, and it has limitations in terms of sensitivity (Kang et al., 2018). Therefore, it is crucial to identify new predictive indicators in this context.

Previous studies have indicated (Kourelis et al., 2022) that excessive activation of systemic inflammatory response is considered an important cause of AKI following cardiac surgery, and PNI is calculated according to the patient’s plasma albumin as well as absolute lymphocyte count, which can reflect both the plasma albumin level and the systemic inflammatory status. Numerous studies have confirmed (Toda & Sugimoto, 2017; Wang et al., 2019) a close association between preoperative hypoalbuminemia and an increased risk of postoperative AKI in CHD children. Research has found (Rauf et al., 2021) that stress and malnutrition during surgery in CHD children can affect postoperative renal and immune function, and AKI can lead to protein metabolism disorders and muscle wasting, thereby affecting the nutritional status and PNI values of the children. Furthermore, postoperative AKI can impair immune function, increase the risk of infections in children, and have a negative impact on postoperative prognosis. Sim et al. (2021) found that the high preoperative PNI was significantly correlated with a lower rate of AKI after open liver resection in patients with hepatocellular carcinoma (95% CI [0.85–0.99], P = 0.021), suggesting that preoperative PNI may serve as a predictive factor for AKI, and surgical prognosis in hepatocellular carcinoma patients undergoing liver resection. Dolapoglu et al. (2019) indicated in their retrospective study that low preoperative PNI levels were associated with higher incidence of postoperative AKI, increased ICU admission rates, and mortality rates. In the present study, preoperative PNI was identified as the independent risk factor for postoperative AKI in CHD children (P < 0.001), and a negative correlation could be observed between preoperative PNI and Scr in CHD children complicated by AKI, suggesting a close association between low preoperative PNI levels and the occurrence of postoperative AKI in CHD children.

NT-proBNP is a hormone produced by the heart and is commonly used to assess cardiac function and the severity of cardiovascular diseases. Relevant studies have indicated that postoperative AKI in CHD children can lead to renal dysfunction, decrease of glomerular filtration rate and disturbances in sodium diuresis hormones, further affecting cardiac load and influencing NT-proBNP levels (Müller et al., 2020). Therefore, observing changes in NT-proBNP levels can be used to evaluate the occurrence of postoperative AKI in children with congenital heart disease. However, some studies have pointed out that postoperative AKI in CHD children can interfere with metabolism and excretion of NT-proBNP, and renal impairment may lead to the accumulation of NT-proBNP in the blood, resulting in elevated levels. However, the levels can be influenced by non-renal factors, which limits the sensitivity of using NT-proBNP alone to predict postoperative AKI in CHD children (Gong et al., 2022).

In the current study, the value of preoperative PNI, NT-proBNP, and their combination in predicting postoperative AKI in CHD children was evaluated using ROC curves. The results showed that the AUCs for preoperative PNI and NT-proBNP in predicting postoperative AKI in CHD children were 0.839 and 0.738, respectively. Among them, the combination of preoperative PNI and NT-proBNP had the highest AUC of 0.907, indicating that the combination of preoperative PNI and NT-proBNP had a higher predictive value in for diagnosing postoperative AKI in CHD children compared to using them individually.

The shortcomings of this study are as follows: this study is a single-center retrospective study, the sample size is small, and more laboratory indicators are not included to analyze the influencing factors of AKI. In the future, multi-center and large sample size prospective studies are needed to further verify the conclusions of this study.

Conclusions

In summary, preoperative PNI combined with NT-proBNP has a high value in predicting postoperative AKI in children with congenital heart disease. By monitoring preoperative PNI and NT-proBNP levels, it is helpful to clinically identify the risk of postoperative AKI in children with congenital heart disease. For patients with low preoperative PNI and high NT-proBNP, it is possible to consider optimizing the nutritional status in advance and strengthening the support of cardiac function, which will help clinicians improve the accuracy of postoperative AKI prediction and reduce the incidence of AKI, thereby improving the overall prognosis after surgery.

Supplemental Information

10.7717/peerj.18085/supp-1 Data S1 Data

Additional Information and Declarations

Competing Interests

Author Contributions

Human Ethics

Data Availability

The authors declare there are no competing interests.

Yan Qiao conceived and designed the experiments, authored or reviewed drafts of the article, and approved the final draft.

Zhenqian Lv analyzed the data, prepared figures and/or tables, and approved the final draft.

Xiaojun Liu analyzed the data, prepared figures and/or tables, and approved the final draft.

Baoguo Zhou analyzed the data, prepared figures and/or tables, and approved the final draft.

Haiping Wang performed the experiments, prepared figures and/or tables, and approved the final draft.

Gang Wang performed the experiments, prepared figures and/or tables, and approved the final draft.

Aiping Xie performed the experiments, prepared figures and/or tables, and approved the final draft.

Chenchen Cheng conceived and designed the experiments, authored or reviewed drafts of the article, and approved the final draft.

The following information was supplied relating to ethical approvals (i.e., approving body and any reference numbers):

This study was approved by the Ethics Committee of Qingdao Cardiovascular Hospital and abided by the ethical guidelines of the Declaration of Helsinki.

The following information was supplied regarding data availability:

The raw data is available in the Supplementary File.
==== Refs
References

Alzahrani et al. (2022) Alzahrani A Alahmadi RA Alghamdi SK AlQurashi RA Al-Hindi MY 2022 Determinants of acute kidney injury in children undergoing cardiopulmonary bypass: single-center experience in Saudi Arabia Cureus 14 12 e32666 10.7759/cureus.32666 36540319
Beken et al. (2021) Beken S Akbulut BB Albayrak E Güner B Ünlü Y Temur B Aydin S Ödemiş E Erek E Korkmaz A 2021 Evaluation of neonatal acute kidney injury after critical congenital heart disease surgery Pediatric Nephrology 36 7 1923 1929 10.1007/s00467-020-04890-z 33492453
Dolapoglu et al. (2019) Dolapoglu A Avci E Kiris T Bugra O 2019 The predictive value of the prognostic nutritional index for postoperative acute kidney injury in patients undergoing on-pump coronary bypass surgery Journal of Cardiothoracic Surgery 14 1 74 10.1186/s13019-019-0898-7 30971264
Fuhrman et al. (2019) Fuhrman DY Nguyen LG Sanchez-de Toledo J Priyanka P Kellum JA 2019 Postoperative acute kidney injury in young adults with congenital heart disease The Annals of Thoracic Surgery 107 5 1416 1420 10.1016/j.athoracsur.2019.01.017 30763561
Gist, Kwiatkowski & Cooper (2018) Gist KM Kwiatkowski DM Cooper DS 2018 Acute kidney injury in congenital heart disease Current Opinion in Cardiology 33 1 101 107 10.1097/HCO.0000000000000473 29028633
Gong et al. (2022) Gong Z Xing D Wu R Zhang S Ye C Chen Y Liu X Chen L Wang T 2022 Prognostic value of N-terminal pro-form B-type natriuretic peptide (NT-proBNP) in patients with congenital heart disease undergoing cardiac surgery: a systematic review and meta-analysis of cohort studies Cardiovascular Diagnosis and Therapy 12 6 853 867 10.21037/cdt-22-155 36605072
The Writing Committee of the Report on Cardiovascular Health and Diseases in China & Hu (2023) The Writing Committee of the Report on Cardiovascular Health and Diseases in China Hu S-S 2023 Report on cardiovascular health and diseases in China 2021: an updated summary Journal of Geriatric Cardiology 20 6 399 430 10.26599/1671-5411.2023.06.001 37416519
Kang et al. (2018) Kang Z Li Z Huang P Luo J Liu P Wang Y Xia T Zhou Y 2018 Remote ischemic preconditioning upregulates microRNA-21 to protect the kidney in children with congenital heart disease undergoing cardiopulmonary bypass Pediatric Nephrology 33 5 911 919 10.1007/s00467-017-3851-9 29197999
Khuong et al. (2021) Khuong JN Wilson TG Iyengar AJ d’Udekem Y 2021 Acute and chronic kidney disease following congenital heart surgery: a review The Annals of Thoracic Surgery 112 5 1698 1706 10.1016/j.athoracsur.2020.10.054 33310148
Khwaja (2012) Khwaja A 2012 KDIGO clinical practice guidelines for acute kidney injury Nephron Clinical Practice 120 4 c179 c184 10.1159/000339789 22890468
Kourelis et al. (2022) Kourelis G Kanakis M Samanidis G Tzannis K Bobos D Kousi T Apostolopoulou S Kakava F Kyriakoulis K Bounta S Rammos S Papagiannis J Giannopoulos N Orfanos SE Dimopoulos G 2022 Acute kidney injury predictors and outcomes after cardiac surgery in children with congenital heart disease: an observational cohort study Diagnostics 12 10 2397 10.3390/diagnostics12102397 36292086
Liu et al. (2023) Liu CC Liu PH Chen HT Chen JY Lee CW Cheng WJ Chen JY Hung KC 2023 Association of preoperative prognostic nutritional index with risk of postoperative acute kidney injury: a meta-analysis of observational studies Nutrients 15 13 2929 10.3390/nu15132929 37447255
Müller et al. (2020) Müller N Rothkegel ST Boerter N Breuer J Freudenthal NJ 2020 Urinary values of NT-proBNP in children with congenital heart disease—is it feasible? Clinica Chimica Acta 509 224 227 10.1016/j.cca.2020.06.015
Nishida et al. (2019) Nishida M Kubo S Morishita Y Nishikawa K Ikeda K Itoi T Hosoi H 2019 Kidney injury biomarkers after cardiac angiography in children with congenital heart disease Congenital Heart Disease 14 6 1087 1093 10.1111/chd.12853 31605509
Parker et al. (2019) Parker DM Everett AD Stabler ME Leyenaar J Vricella L Jacobs JP Thiessen-Philbrook H Parikh C Greenberg JH Brown JR 2019 The association between cardiac biomarker NT-proBNP and 30-day readmission or mortality after pediatric congenital heart surgery World Journal for Pediatric & Congenital Heart Surgery 10 4 446 453 10.1177/2150135119842864 31307305
Rauf et al. (2021) Rauf A Joshi RK Aggarwal N Agarwal M Kumar M Dinand V Joshi R 2021 Effect of Albumin Addition to Cardiopulmonary Bypass Prime on Outcomes in Children Undergoing Open-Heart Surgery (EACPO study)-a randomized controlled trial World Journal for Pediatric & Congenital Heart Surgery 12 1 61 69 10.1177/2150135120959088 33078664
Sim et al. (2021) Sim JH Jun IG Moon YJ Jeon AR Kim SH Kim B Song JG 2021 Association of preoperative prognostic nutritional index and postoperative acute kidney injury in patients who underwent hepatectomy for hepatocellular carcinoma Journal of Personalized Medicine 11 5 428 10.3390/jpm11050428 34069960
Toda & Sugimoto (2017) Toda Y Sugimoto K 2017 AKI after pediatric cardiac surgery for congenital heart diseases-recent developments in diagnostic criteria and early diagnosis by biomarkers Journal of Intensive Care 5 49 10.1186/s40560-017-0242-z 28729908
Van den Eynde et al. (2021) Van den Eynde J Cloet N Van Lerberghe R Sá MPBO Vlasselaers D Toelen J Verbakel JY Budts W Gewillig M Kutty S Pottel H Mekahli D 2021 Strategies to prevent acute kidney injury after pediatric cardiac surgery: a network meta-analysis Clinical Journal of the American Society of Nephrology 16 10 1480 1490 10.2215/CJN.05800421 34620647
Wang et al. (2019) Wang C Fu P Wang Y Yang K Peng YG Li J Gong J Wang J Luo Q Gao Y Wang S Tian Y Yan F 2019 Epidemiology of acute kidney injury among paediatric patients after repair of anomalous origin of the left coronary artery from the pulmonary artery European Journal of Cardio-Thoracic Surgery 56 5 883 890 10.1093/ejcts/ezz090 31005966
Xie et al. (2022) Xie T Xin Q Chen R Zhang X Zhang F Ren H Liu C Zhang J 2022 Clinical value of prognostic nutritional index and neutrophil-to-lymphocyte ratio in prediction of the development of sepsis-induced kidney injury Disease Markers 2022 1449758 10.1155/2022/1449758 35711566
Xu et al. (2022) Xu Z Chen X Yuan J Wang C An J Ma X 2022 Correlations of preoperative systematic immuno-inflammatory index and prognostic nutrition index with a prognosis of patients after radical gastric cancer surgery Surgery 172 1 150 159 10.1016/j.surg.2022.01.006 35168816
Xu et al. (2018) Xu X Nie S Zhang A Mao J Liu HP Xia H Xu H Liu Z Feng S Zhou W Liu X Yang Y Tao Y Feng Y Chen C Wang M Zha Y Feng JH Li Q Ge S Chen J He Y Teng S Hao C Liu B-C Tang Y He W He P Hou FF 2018 Acute kidney injury among hospitalized children in China Clinical Journal of the American Society of Nephrology 13 12 1791 1800 10.2215/CJN.00800118 30287424
